Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.
about
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer modelsSentinel lymph node biopsy in bladder cancer: Systematic review and technology updateBeyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?Nanoparticles for biomedical imaging: fundamentals of clinical translationPreclinical lymphatic imaging.Optical imaging in breast cancer diagnosis: the next evolutionA Quick Responsive Fluorogenic pH Probe for Ovarian Tumor Imaging.Near infrared fluorescent optical imaging for nodal staging.Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging.Exogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives.Label-free optical imaging of lymphatic vessels within tissue beds in vivoNear infrared fluorescent chlorophyll nanoscale liposomes for sentinel lymph node mapping.Real-time intraoperative assessment of the extrahepatic bile ducts in rats and pigs using invisible near-infrared fluorescent light.Intraoperative near infrared fluorescence guided identification of the ureters using low dose methylene blue: a first in human experience.Quantum dots for cancer diagnosis and therapy: biological and clinical perspectives.New technologies for human cancer imaging.Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore.The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping.A review of sentinel lymph node evaluation and the need for its incorporation into veterinary oncology.Nanoparticles for multimodal in vivo imaging in nanomedicine.Image-guided sentinel lymph node mapping and nanotechnology-based nodal treatment in lung cancer using invisible near-infrared fluorescent light.Quantum dots in cancer therapy.Urinary bladder cancer in dogs, a naturally occurring model for cancer biology and drug development.Usage of invisible near infrared light (NIR) fluorescence with indocyanine green (ICG) and methylene blue (MB) in urological oncology. Part 1.Molecular Targeted Fluorescence-Guided Intraoperative Imaging of Bladder Cancer Nodal Drainage Using Indocyanine Green During Radical and Partial Cystectomy.Dynamic visualization of RGD-quantum dot binding to tumor neovasculature and extravasation in multiple living mouse models using intravital microscopy.Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice.Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature.The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine.Fluorescence imaging of stem cells, cancer cells and semi-thin sections of tissues using silica-coated CdSe quantum dots.
P2860
Q24657493-C8023A51-5390-4050-B248-EC938B6E2EAEQ27027693-3A4EC683-83CB-4C4F-B627-827526D81AF9Q28079221-96362902-FCC2-4025-A3E5-54026BE8C69BQ28385644-29CF182A-B243-497F-9EC3-F1DDACDB19D4Q30465292-62653925-207D-45C0-8C78-26B1E5E51982Q30585402-C028A6AE-9EF2-4206-91BE-6C8732C3C91FQ30660777-9CF73922-5475-435B-ACE1-19BAAED5232AQ34038991-9DBBB93E-F9EE-42DB-808B-41CEC64435BFQ34458231-B6A3978C-7625-405D-A720-38C5D5CE4358Q34954961-5DE56FCE-85C4-4CE7-A277-9E8A94C1385AQ35018333-C635E76A-ED2A-49E4-9F74-183B1AB13429Q36079928-F9E964B4-110F-4CFC-907E-F66DBA4B6BA9Q36757097-084FA89C-03B2-46D0-B877-9D90FD23057DQ36941026-B37125BF-CA7B-4047-8BC0-2C4253D79FA4Q37130501-3D4AD4C2-D400-4E57-89C5-3B10213C9524Q37246614-EAC24F36-EF66-40F8-B2EE-A40D1BA65D72Q37269743-84047AEA-7F28-45C8-B9C9-DD8D4257B80CQ37409257-90A9CBD8-9ADC-4ACA-835C-691CDE873D41Q37488370-4195B6EC-4645-4AFD-9AFA-4A6B52993937Q37558594-5DC9A938-AACE-4544-930C-A3ECBCD06648Q37708403-3699BBD4-F03B-4179-970A-7DA44845B144Q37968640-BFA324B9-AF58-4FAF-B579-B7C80A7C6817Q38220806-859A40BA-C72E-4D29-AC1C-2571947A03C3Q38241543-9F928A9C-B56B-4183-869E-A8CB054428F0Q38830012-C5BEA594-388D-4651-986D-4E7F4CA695F5Q39652458-CF955AEF-7DEE-4DC3-9C29-E8AC81A2FB37Q42723945-264752A8-BA0C-416E-9E35-8673AC65135CQ42873376-008286D3-B75D-44EE-A68D-9FBA48497A4DQ48232164-11984C56-F03A-448A-822D-35C1351F47B4Q50689675-8B12EC0F-FFFE-4A03-A417-23CEA78FF0C7
P2860
Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Sentinel lymph node mapping of ...... models using invisible light.
@ast
Sentinel lymph node mapping of ...... models using invisible light.
@en
type
label
Sentinel lymph node mapping of ...... models using invisible light.
@ast
Sentinel lymph node mapping of ...... models using invisible light.
@en
prefLabel
Sentinel lymph node mapping of ...... models using invisible light.
@ast
Sentinel lymph node mapping of ...... models using invisible light.
@en
P2093
P2860
P1433
P1476
Sentinel lymph node mapping of ...... models using invisible light.
@en
P2093
Alec M Degrand
Ann B Weil
Deborah W Knapp
Jacqueline D Niles
José A Ramos-Vara
Larry G Adams
Michael A O'Donnell
Michael D Lucroy
P2860
P304
P356
10.1016/J.EURURO.2007.07.007
P407
P577
2007-07-16T00:00:00Z